APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 7

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metabotropic Glutamate Receptor 7 Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 7 Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 7 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 7 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 7 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 7 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Metabotropic Glutamate Receptor 7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metabotropic Glutamate Receptor 7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metabotropic Glutamate Receptor 7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metabotropic Glutamate Receptor 7 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Metabotropic Glutamate Receptor 7 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bio-Pharm Solutions Co Ltd and Pragma Therapeutics SAS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Metabotropic Glutamate Receptor 7, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metabotropic Glutamate Receptor 7, also provides the sales of main regions and countries. Of the upcoming market potential for Metabotropic Glutamate Receptor 7, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metabotropic Glutamate Receptor 7 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metabotropic Glutamate Receptor 7 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Metabotropic Glutamate Receptor 7 sales, projected growth trends, production technology, application and end-user industry.

Metabotropic Glutamate Receptor 7 Segment by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bio-Pharm Solutions Co Ltd

Pragma Therapeutics SAS

Metabotropic Glutamate Receptor 7 Segment by Type

PGT-117

JBPOS-0101

ADX-71743

Others

Metabotropic Glutamate Receptor 7 Segment by Application

Infantile Spasm

Generalized Anxiety Disorder

Status Epilepticus

Others

Metabotropic Glutamate Receptor 7 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 7 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 7 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 7.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Metabotropic Glutamate Receptor 7 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metabotropic Glutamate Receptor 7 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabotropic Glutamate Receptor 7 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PGT-117 Major Manufacturers Table 3. JBPOS-0101 Major Manufacturers Table 4. ADX-71743 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Infantile Spasm Major Manufacturers Table 8. Generalized Anxiety Disorder Major Manufacturers Table 9. Status Epilepticus Major Manufacturers Table 10. Others Major Manufacturers Table 11. Metabotropic Glutamate Receptor 7 Industry Trends Table 12. Metabotropic Glutamate Receptor 7 Industry Drivers Table 13. Metabotropic Glutamate Receptor 7 Industry Opportunities and Challenges Table 14. Metabotropic Glutamate Receptor 7 Industry Restraints Table 15. Global Metabotropic Glutamate Receptor 7 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Metabotropic Glutamate Receptor 7 Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Metabotropic Glutamate Receptor 7 Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2021-2026) Table 19. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2027-2032) Table 20. Global Metabotropic Glutamate Receptor 7 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Metabotropic Glutamate Receptor 7 Sales by Region (2021-2026) & (W Units) Table 22. Global Metabotropic Glutamate Receptor 7 Sales by Region (2027-2032) & (W Units) Table 23. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2021-2026) Table 24. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2027-2032) Table 25. Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Manufacturers (2021-2026) Table 29. Global Metabotropic Glutamate Receptor 7 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 7 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Metabotropic Glutamate Receptor 7 Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Metabotropic Glutamate Receptor 7 Manufacturers, Product Type & Application Table 33. Global Metabotropic Glutamate Receptor 7 Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Metabotropic Glutamate Receptor 7 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Metabotropic Glutamate Receptor 7 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2021-2026) Table 40. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2027-2032) Table 41. Global Metabotropic Glutamate Receptor 7 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 43. Global Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 44. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2021-2026) Table 45. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2027-2032) Table 46. Global Metabotropic Glutamate Receptor 7 Price by Type (2021-2026) & (US$/Unit) Table 47. Global Metabotropic Glutamate Receptor 7 Price by Type (2027-2032) & (US$/Unit) Table 48. Global Metabotropic Glutamate Receptor 7 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2021-2026) Table 52. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2027-2032) Table 53. Global Metabotropic Glutamate Receptor 7 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 55. Global Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 56. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2021-2026) Table 57. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2027-2032) Table 58. Global Metabotropic Glutamate Receptor 7 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Metabotropic Glutamate Receptor 7 Price by Application (2027-2032) & (US$/Unit) Table 60. Addex Therapeutics Ltd Company Information Table 61. Addex Therapeutics Ltd Business Overview Table 62. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Portfolio Table 64. Addex Therapeutics Ltd Recent Development Table 65. Aevi Genomic Medicine Inc Company Information Table 66. Aevi Genomic Medicine Inc Business Overview Table 67. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Portfolio Table 69. Aevi Genomic Medicine Inc Recent Development Table 70. Bio-Pharm Solutions Co Ltd Company Information Table 71. Bio-Pharm Solutions Co Ltd Business Overview Table 72. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Portfolio Table 74. Bio-Pharm Solutions Co Ltd Recent Development Table 75. Pragma Therapeutics SAS Company Information Table 76. Pragma Therapeutics SAS Business Overview Table 77. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Portfolio Table 79. Pragma Therapeutics SAS Recent Development Table 80. North America Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 83. North America Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 84. North America Metabotropic Glutamate Receptor 7 Sales Price by Type (2021-2026) & (US$/Unit) Table 85. North America Metabotropic Glutamate Receptor 7 Sales Price by Type (2027-2032) & (US$/Unit) Table 86. North America Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 89. North America Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 90. North America Metabotropic Glutamate Receptor 7 Sales Price by Application (2021-2026) & (US$/Unit) Table 91. North America Metabotropic Glutamate Receptor 7 Sales Price by Application (2027-2032) & (US$/Unit) Table 92. North America Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 94. North America Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 95. North America Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 96. North America Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 97. North America Metabotropic Glutamate Receptor 7 Sales by Country (2027-2032) & (W Units) Table 98. North America Metabotropic Glutamate Receptor 7 Sales Price by Country (2021-2026) & (US$/Unit) Table 99. North America Metabotropic Glutamate Receptor 7 Sales Price by Country (2027-2032) & (US$/Unit) Table 100. United States Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 101. Canada Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 102. Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 105. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 106. Europe Metabotropic Glutamate Receptor 7 Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe Metabotropic Glutamate Receptor 7 Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 111. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 112. Europe Metabotropic Glutamate Receptor 7 Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe Metabotropic Glutamate Receptor 7 Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 118. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 119. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2027-2032) & (W Units) Table 120. Europe Metabotropic Glutamate Receptor 7 Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe Metabotropic Glutamate Receptor 7 Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 123. France Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 124. U.K. Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 125. Italy Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 127. Nordic Countries Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 128. China Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 129. China Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 130. China Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 131. China Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 132. China Metabotropic Glutamate Receptor 7 Sales Price by Type (2021-2026) & (US$/Unit) Table 133. China Metabotropic Glutamate Receptor 7 Sales Price by Type (2027-2032) & (US$/Unit) Table 134. China Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 135. China Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 136. China Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 137. China Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 138. China Metabotropic Glutamate Receptor 7 Sales Price by Application (2021-2026) & (US$/Unit) Table 139. China Metabotropic Glutamate Receptor 7 Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Asia Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 143. Asia Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 144. Asia Metabotropic Glutamate Receptor 7 Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Asia Metabotropic Glutamate Receptor 7 Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Asia Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 149. Asia Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 150. Asia Metabotropic Glutamate Receptor 7 Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Asia Metabotropic Glutamate Receptor 7 Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Asia Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Asia Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 156. Asia Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 157. Asia Metabotropic Glutamate Receptor 7 Sales by Country (2027-2032) & (W Units) Table 158. Asia Metabotropic Glutamate Receptor 7 Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Asia Metabotropic Glutamate Receptor 7 Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Japan Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 161. South Korea Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 162. India Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 163. Australia Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 164. China Taiwan Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 165. Southeast Asia Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 166. SAMEA Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2026) & (US$ Million) Table 167. SAMEA Metabotropic Glutamate Receptor 7 Revenue by Type (2027-2032) & (US$ Million) Table 168. SAMEA Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 169. SAMEA Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 170. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Type (2021-2026) & (US$/Unit) Table 171. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Type (2027-2032) & (US$/Unit) Table 172. SAMEA Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2026) & (US$ Million) Table 173. SAMEA Metabotropic Glutamate Receptor 7 Revenue by Application (2027-2032) & (US$ Million) Table 174. SAMEA Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 175. SAMEA Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 176. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Application (2021-2026) & (US$/Unit) Table 177. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Application (2027-2032) & (US$/Unit) Table 178. SAMEA Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. SAMEA Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. SAMEA Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. SAMEA Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 182. SAMEA Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 183. SAMEA Metabotropic Glutamate Receptor 7 Sales by Country (2027-2032) & (W Units) Table 184. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Country (2021-2026) & (US$/Unit) Table 185. SAMEA Metabotropic Glutamate Receptor 7 Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Brazil Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 187. Argentina Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 188. Chile Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 189. Colombia Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 190. Peru Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 191. Saudi Arabia Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 192. Israel Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 193. UAE Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 194. Turkey Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 195. Iran Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 196. Egypt Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Metabotropic Glutamate Receptor 7 Distributors List Table 200. Metabotropic Glutamate Receptor 7 Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 7 Image Figure 2. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 7 Market Size Share 2021 VS 2025 VS 2032 Figure 4. PGT-117 Image Figure 5. JBPOS-0101 Image Figure 6. ADX-71743 Image Figure 7. Others Image Figure 8. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Metabotropic Glutamate Receptor 7 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Infantile Spasm Image Figure 11. Generalized Anxiety Disorder Image Figure 12. Status Epilepticus Image Figure 13. Others Image Figure 14. Global Metabotropic Glutamate Receptor 7 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Metabotropic Glutamate Receptor 7 Revenue (2021-2032) & (US$ Million) Figure 16. Global Metabotropic Glutamate Receptor 7 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2021-2032) Figure 19. Global Metabotropic Glutamate Receptor 7 Sales (2021-2032) & (W Units) Figure 20. Global Metabotropic Glutamate Receptor 7 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Metabotropic Glutamate Receptor 7 Sales YoY (2021-2032) & (W Units) Figure 23. Europe Metabotropic Glutamate Receptor 7 Sales YoY (2021-2032) & (W Units) Figure 24. China Metabotropic Glutamate Receptor 7 Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Metabotropic Glutamate Receptor 7 Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Metabotropic Glutamate Receptor 7 Sales YoY (2021-2032) & (W Units) Figure 27. Global Metabotropic Glutamate Receptor 7 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Metabotropic Glutamate Receptor 7 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2021-2032) Figure 33. Global Metabotropic Glutamate Receptor 7 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2021-2032) Figure 36. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2021-2032) Figure 39. Global Metabotropic Glutamate Receptor 7 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2021-2032) Figure 42. North America Metabotropic Glutamate Receptor 7 Revenue Share by Type (2021-2032) Figure 43. North America Metabotropic Glutamate Receptor 7 Sales Share by Type (2021-2032) Figure 44. North America Metabotropic Glutamate Receptor 7 Revenue Share by Application (2021-2032) Figure 45. North America Metabotropic Glutamate Receptor 7 Sales Share by Application (2021-2032) Figure 46. North America Metabotropic Glutamate Receptor 7 Revenue Share by Country (2021-2032) Figure 47. North America Metabotropic Glutamate Receptor 7 Sales Share by Country (2021-2032) Figure 48. Europe Metabotropic Glutamate Receptor 7 Revenue Share by Type (2021-2032) Figure 49. Europe Metabotropic Glutamate Receptor 7 Sales Share by Type (2021-2032) Figure 50. Europe Metabotropic Glutamate Receptor 7 Revenue Share by Application (2021-2032) Figure 51. Europe Metabotropic Glutamate Receptor 7 Sales Share by Application (2021-2032) Figure 52. Europe Metabotropic Glutamate Receptor 7 Revenue Share by Country (2021-2032) Figure 53. Europe Metabotropic Glutamate Receptor 7 Sales Share by Country (2021-2032) Figure 54. China Metabotropic Glutamate Receptor 7 Revenue Share by Type (2021-2032) Figure 55. China Metabotropic Glutamate Receptor 7 Sales Share by Type (2021-2032) Figure 56. China Metabotropic Glutamate Receptor 7 Revenue Share by Application (2021-2032) Figure 57. China Metabotropic Glutamate Receptor 7 Sales Share by Application (2021-2032) Figure 58. Asia Metabotropic Glutamate Receptor 7 Revenue Share by Type (2021-2032) Figure 59. Asia Metabotropic Glutamate Receptor 7 Sales Share by Type (2021-2032) Figure 60. Asia Metabotropic Glutamate Receptor 7 Revenue Share by Application (2021-2032) Figure 61. Asia Metabotropic Glutamate Receptor 7 Sales Share by Application (2021-2032) Figure 62. Asia Metabotropic Glutamate Receptor 7 Revenue Share by Country (2021-2032) Figure 63. Asia Metabotropic Glutamate Receptor 7 Sales Share by Country (2021-2032) Figure 64. SAMEA Metabotropic Glutamate Receptor 7 Revenue Share by Type (2021-2032) Figure 65. SAMEA Metabotropic Glutamate Receptor 7 Sales Share by Type (2021-2032) Figure 66. SAMEA Metabotropic Glutamate Receptor 7 Revenue Share by Application (2021-2032) Figure 67. SAMEA Metabotropic Glutamate Receptor 7 Sales Share by Application (2021-2032) Figure 68. SAMEA Metabotropic Glutamate Receptor 7 Revenue Share by Country (2021-2032) Figure 69. SAMEA Metabotropic Glutamate Receptor 7 Sales Share by Country (2021-2032) Figure 70. Metabotropic Glutamate Receptor 7 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Metabotropic Glutamate Receptor 7 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • PGT-117
  • JBPOS-0101
  • ADX-71743
  • Others
Applications
  • Infantile Spasm
  • Generalized Anxiety Disorder
  • Status Epilepticus
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bio-Pharm Solutions Co Ltd
  • Pragma Therapeutics SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metabotropic Glutamate Receptor 7 Market by Type
  3. 1.2.1 Global Metabotropic Glutamate Receptor 7 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PGT-117
  5. 1.2.3 JBPOS-0101
  6. 1.2.4 ADX-71743
  7. 1.2.5 Others
  8. 1.3 Metabotropic Glutamate Receptor 7 Market by Application
  9. 1.3.1 Global Metabotropic Glutamate Receptor 7 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Infantile Spasm
  11. 1.3.3 Generalized Anxiety Disorder
  12. 1.3.4 Status Epilepticus
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Metabotropic Glutamate Receptor 7 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 7 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 7 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 7 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 7 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Metabotropic Glutamate Receptor 7 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Metabotropic Glutamate Receptor 7 Revenue by Region
  3. 3.2.1 Global Metabotropic Glutamate Receptor 7 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metabotropic Glutamate Receptor 7 Revenue by Region (2021-2026)
  5. 3.2.3 Global Metabotropic Glutamate Receptor 7 Revenue by Region (2027-2032)
  6. 3.2.4 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Metabotropic Glutamate Receptor 7 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Metabotropic Glutamate Receptor 7 Sales by Region
  9. 3.4.1 Global Metabotropic Glutamate Receptor 7 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Metabotropic Glutamate Receptor 7 Sales by Region (2021-2026)
  11. 3.4.3 Global Metabotropic Glutamate Receptor 7 Sales by Region (2027-2032)
  12. 3.4.4 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers
  2. 4.1.1 Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Metabotropic Glutamate Receptor 7 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers
  6. 4.2.1 Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Metabotropic Glutamate Receptor 7 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Metabotropic Glutamate Receptor 7 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Metabotropic Glutamate Receptor 7 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Metabotropic Glutamate Receptor 7 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Metabotropic Glutamate Receptor 7 Manufacturers, Product Type & Application
  13. 4.7 Global Metabotropic Glutamate Receptor 7 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Metabotropic Glutamate Receptor 7 Market CR5 and HHI
  16. 4.8.2 2025 Metabotropic Glutamate Receptor 7 Tier 1, Tier 2, and Tier 3
5 Metabotropic Glutamate Receptor 7 Market by Type
  1. 5.1 Global Metabotropic Glutamate Receptor 7 Revenue by Type
  2. 5.1.1 Global Metabotropic Glutamate Receptor 7 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Metabotropic Glutamate Receptor 7 Sales by Type
  6. 5.2.1 Global Metabotropic Glutamate Receptor 7 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Metabotropic Glutamate Receptor 7 Price by Type
6 Metabotropic Glutamate Receptor 7 Market by Application
  1. 6.1 Global Metabotropic Glutamate Receptor 7 Revenue by Application
  2. 6.1.1 Global Metabotropic Glutamate Receptor 7 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Metabotropic Glutamate Receptor 7 Sales by Application
  6. 6.2.1 Global Metabotropic Glutamate Receptor 7 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Metabotropic Glutamate Receptor 7 Price by Application
7 Company Profiles
  1. 7.1 Addex Therapeutics Ltd
  2. 7.1.1 Addex Therapeutics Ltd Company Information
  3. 7.1.2 Addex Therapeutics Ltd Business Overview
  4. 7.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Portfolio
  6. 7.1.5 Addex Therapeutics Ltd Recent Developments
  7. 7.2 Aevi Genomic Medicine Inc
  8. 7.2.1 Aevi Genomic Medicine Inc Company Information
  9. 7.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 7.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Portfolio
  12. 7.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 7.3 Bio-Pharm Solutions Co Ltd
  14. 7.3.1 Bio-Pharm Solutions Co Ltd Company Information
  15. 7.3.2 Bio-Pharm Solutions Co Ltd Business Overview
  16. 7.3.3 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Portfolio
  18. 7.3.5 Bio-Pharm Solutions Co Ltd Recent Developments
  19. 7.4 Pragma Therapeutics SAS
  20. 7.4.1 Pragma Therapeutics SAS Company Information
  21. 7.4.2 Pragma Therapeutics SAS Business Overview
  22. 7.4.3 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Portfolio
  24. 7.4.5 Pragma Therapeutics SAS Recent Developments
8 North America
  1. 8.1 North America Metabotropic Glutamate Receptor 7 Market Size by Type
  2. 8.1.1 North America Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032)
  3. 8.1.2 North America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032)
  4. 8.1.3 North America Metabotropic Glutamate Receptor 7 Price by Type (2021-2032)
  5. 8.2 North America Metabotropic Glutamate Receptor 7 Market Size by Application
  6. 8.2.1 North America Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032)
  7. 8.2.2 North America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032)
  8. 8.2.3 North America Metabotropic Glutamate Receptor 7 Price by Application (2021-2032)
  9. 8.3 North America Metabotropic Glutamate Receptor 7 Market Size by Country
  10. 8.3.1 North America Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Metabotropic Glutamate Receptor 7 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Metabotropic Glutamate Receptor 7 Market Size by Type
  2. 9.1.1 Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032)
  4. 9.1.3 Europe Metabotropic Glutamate Receptor 7 Price by Type (2021-2032)
  5. 9.2 Europe Metabotropic Glutamate Receptor 7 Market Size by Application
  6. 9.2.1 Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032)
  8. 9.2.3 Europe Metabotropic Glutamate Receptor 7 Price by Application (2021-2032)
  9. 9.3 Europe Metabotropic Glutamate Receptor 7 Market Size by Country
  10. 9.3.1 Europe Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Metabotropic Glutamate Receptor 7 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Metabotropic Glutamate Receptor 7 Market Size by Type
  2. 10.1.1 China Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032)
  3. 10.1.2 China Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032)
  4. 10.1.3 China Metabotropic Glutamate Receptor 7 Price by Type (2021-2032)
  5. 10.2 China Metabotropic Glutamate Receptor 7 Market Size by Application
  6. 10.2.1 China Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032)
  7. 10.2.2 China Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032)
  8. 10.2.3 China Metabotropic Glutamate Receptor 7 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metabotropic Glutamate Receptor 7 Market Size by Type
  2. 11.1.1 Asia Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032)
  4. 11.1.3 Asia Metabotropic Glutamate Receptor 7 Price by Type (2021-2032)
  5. 11.2 Asia Metabotropic Glutamate Receptor 7 Market Size by Application
  6. 11.2.1 Asia Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032)
  8. 11.2.3 Asia Metabotropic Glutamate Receptor 7 Price by Application (2021-2032)
  9. 11.3 Asia Metabotropic Glutamate Receptor 7 Market Size by Country
  10. 11.3.1 Asia Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Metabotropic Glutamate Receptor 7 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metabotropic Glutamate Receptor 7 Market Size by Type
  2. 12.1.1 SAMEA Metabotropic Glutamate Receptor 7 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Metabotropic Glutamate Receptor 7 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Metabotropic Glutamate Receptor 7 Price by Type (2021-2032)
  5. 12.2 SAMEA Metabotropic Glutamate Receptor 7 Market Size by Application
  6. 12.2.1 SAMEA Metabotropic Glutamate Receptor 7 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Metabotropic Glutamate Receptor 7 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Metabotropic Glutamate Receptor 7 Price by Application (2021-2032)
  9. 12.3 SAMEA Metabotropic Glutamate Receptor 7 Market Size by Country
  10. 12.3.1 SAMEA Metabotropic Glutamate Receptor 7 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Metabotropic Glutamate Receptor 7 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Metabotropic Glutamate Receptor 7 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Metabotropic Glutamate Receptor 7 Value Chain Analysis
  2. 13.1.1 Metabotropic Glutamate Receptor 7 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Metabotropic Glutamate Receptor 7 Production Mode & Process
  6. 13.2 Metabotropic Glutamate Receptor 7 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Metabotropic Glutamate Receptor 7 Distributors
  9. 13.2.3 Metabotropic Glutamate Receptor 7 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst